Business
Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds
MIAMI, Sept. 23, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under
About this update from Innovative Eyewear, Inc.
[{"type":"text","content":"MIAMI, Sept. 23, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. (\"Innovative Eyewear\" or the \"Company\") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 263,160 shares of the Company's common stock originally issued by the Company on May 29, 2024, each having an original exercise price of $9.50 per share, at an exercise price of $9.875 per share. The closing of the warrant exercise transaction is expected to occur on or about September 24, 2024, subject to satisfaction of customary closing conditions.\n\n \n \n \n \n \n \n\n \nH.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.\nThe shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-279873).\nThe gross proceeds to the Company from the exercise of the warrants are expected to be approximately $2.6 million, prior to deducting placement agent fees and offering expenses. The Company expects to use the net proceeds from the transaction for working capital and general corporate purposes.\nIn consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series E warrants to purchase up to an aggregate of 263,160 shares of common stock and new unregistered Series F warrants to purchase up to an aggregate of 526,320 shares of common stock. The new Series E and Series F warrants will have an exercise price of $9.50 per share. The new Series E warrants will be exercisable immediately and will expire five years from the date of issuance and the new Series F warrants will be exercisable immediately and will expire eighteen months from the date of issuance.\nThe new warrants described above are being offered in a private placement and, along with the shares of common stock issuable upon exercise of the new warrants, have not been registered under the Securities Act of 1933, as amended (the \"1933 Act\"), or applicable state securities laws. Accordingly, the new warrants and shares of common stock issuable upon the exercise of the new warrants may not be offered or sold in the United States except pursuant to an effective ...